Doping Concerns Rise Around Pogacar and UAE Team Emirates During Tour de France
The performance of Tadej Pogacar in the 2025 Tour de France stirs renewed doping allegations.
Key Points
- • Pogacar’s dominance in the Tour has raised doping suspicions.
- • UAE Team Emirates has achieved 101 stage victories since 2017.
- • The last positive doping case in the Tour was in 2017.
- • Experts question the legitimacy of exceptional performances in cycling.
Tadej Pogacar’s outstanding performances in the ongoing 2025 Tour de France have reignited allegations and concerns about doping within professional cycling. Pogacar, a member of UAE Team Emirates, has played a pivotal role in the team’s remarkable success, contributing to a staggering total of 101 stage victories in Grand Tours since 2017.
This dominance has raised eyebrows, particularly as the discipline has faced a history marred by doping scandals. Experts have begun to express skepticism about the legitimacy of such achievements, especially given that the last documented positive doping case in the Tour dates back to 2017. Despite this relative calm, Pogacar's overwhelming success has led to questions about whether some athletes might be using sophisticated, undetectable performance-enhancing methods.
Commentators in the cycling community have voiced their concerns, with one remarking, "Everything will end badly, but when?" illustrating deep-rooted skepticism about the integrity of the sport today. With the Tour's ongoing developments, anti-doping measures and their efficacy remain under scrutiny as Pogacar continues to lead the race with remarkable prowess, further deepening the controversy surrounding his achievements and those of his team.